Disc Medicine, Inc DEFA14A, filed Apr 24, 2025
Disc Medicine, Inc. (IRON)
|
|
UNITED STATES |
|
SECURITIES AND EXCHANGE COMMISSION |
|
Washington, D.C. 20549 |
|
|
|
|
|
SCHEDULE 14A |
|
Proxy Statement Pursuant to Section 14(a) of the |
|
Securities Exchange Act of 1934 (Amendment No. ) |
|
|
|
|
|
Filed by the Registrant ☒ |
|
|
|
Filed by a Party other than the Registrant ☐ |
|
|
|
Check the appropriate box: |
|
|
|
☐ |
Preliminary Proxy Statement |
|
|
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
|
☐ |
Definitive Proxy Statement |
|
|
☒ |
Definitive Additional Materials |
|
|
☐ |
Soliciting Material under §240.14a-12 |
|
|
DISC MEDICINE, INC. |
|
(Name of Registrant as specified in its charter) |
|
|
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
|
|
|
Payment of Filing Fee (Check all boxes that apply): |
|
|
|
☒ |
No fee required. |
|
|
☐ |
Fee paid previously with preliminary materials. |
|
|
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
|
